MedTrace Logo

Anti-TNF Therapy and Nerve Conduction Studies in Ankylosing Spondylitis

NCT04943237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-06-29

No results posted yet for this study

Summary

Patients with ankylosing spondylitis were divided into 2 groups as anti-TNF and conventional therapy according to the treatments they were using for the last 5 years. Nerve conduction studies in the upper and lower extremities of the patients were compared.

Conditions

Interventions

DRUG

Anti-TNF agents

Group of patients using anti-TNF for the last 5 years.

DRUG

Conventional therapy users for the last 5 years

Group of patients not using anti-TNF. Group of patients using conventional therapy (non -steroid anti-inflammatory drugs and/or salazopyrin) for the last 5 years

Sponsors & Collaborators

  • Istanbul Physical Medicine Rehabilitation Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Betül Yavuz Keleş, MD · Istanbul physical Medicine and Rehabilitation Training and Research Hospital

  • Ayşe Nur Bardak, prof · Istanbul physical Medicine and Rehabilitation Training and Research Hospital

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2019-10-01
Completion
2019-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943237 on ClinicalTrials.gov